E-drug: Dec 4 Columbia/CPTech R&D event
---------------------------------------------------------------------
This is the most recent version of the agenda for a December 4 event
at Columbia University on Access to Medicines and the Financing of
Innovations in Health Care. The web page for the event at Columbia
(which should be updated later today) is here (please 'repair' url!):
http://www.earthinstitute.columbia.edu/cgsd/documents/Medical_R_a
nd_D.pdf
Workshop on
Access to Medicines and the Financing of Innovations in
Health Care
Hosted by
The Program on Science, Technology, and Global Development
The Earth Institute at Columbia University
and the
The Consumer Project on Technology
Washington, DC
December 4, 2003
Lerner Hall (room 569), Columbia University
Can we promote "access to medicines for all," and finance faster,
more appropriate innovation in health care?
Paragraph 4 of the Doha Declaration on Health, calls upon member
countries to implement patent laws in a manner supportive of public
health, and in particular "to promote access to medicines for all." The
financing of medical R&D now relies heavily on the enforcement of
intellectual property rights. A growing body of evidence suggests that
ever-higher levels of IPR protection may distort the research agenda
and slow the pace of follow-on inventions, as well as limit access to
existing inventions. This workshop examines these tensions, and
considers alternative approaches to financing the development of
new medical inventions.
To register for the event:
Joy Spencer, CPTech
Phone 1.202.387.8030
joy.spencer@cptech.org
Will Masters, Columbia University
Phone 1.212.854.7633
wmasters@ei.columbia.edu
Access to Medicines and the Financing of Innovations in Health Care
December 4, 2003
Agenda (as of November 26)
8:45-9:00 Welcome and introductions
Jeffrey Sachs, Director, the Earth Institute, Columbia University
9:00-10:00 Proposals to Address Market Failures in R&D - I
Richard Nelson, George Blumenthal Professor of International and
Public Affairs, Business and Law, Columbia University (Moderator)
James Love, Director, CPTech - New Global Framework for Funding
R&D (20 minutes)
Tim Hubbard, Head of Human Genome Analysis, Wellcome
Trust/Sanger Institute, Four Alternatives to the Price System: (1) A
Prize System, (2) Public Institutions to Develop New Drugs, (3) Open
Collaborative Development Models for Public Goods, and (4)
Competitive Intermediators
Discussion
10:00-10:15 Coffee Break
10:15-11:15 Proposals to Address Market Failures in R&D - II
Will Masters, Center on Globalization and Sustainable Development,
Columbia University, (Moderator)
Henry Grabowski, Director of the Program in Pharmaceuticals and
Health Economics, Duke University - New subsidies for neglected
diseases
Jerome Reichman, Bunyan S. Womble Professor of Law, Duke
University, and Tracy Lewis, Fuqua School of Business, Duke
University. Reform of Intellectual Property Rules: The Replacement of
Exclusive Rights with Liability rules for the Protection of Investment in
R&D
11:15-12:30 Reactions and discussion
Sakiko Fukuda-Parr, Director & Editor in Chief of Human
Development Report, UNDP (moderator)
Spring Gombe, Health Action International
Bruce Lehman, President and CEO, International Intellectual Property
Institute
Brandon Lerch, Legislative Assistant, Office of Congressman
Gutknecht
Discussion
12:30-1:30 Lunch break
1:30-2:30 Costs of patent protection and benefits of innovation
Juan Rovira, Senior Health Economist, World Bank (Moderator)
Frank Lichtenberg, Professor, Columbia Business School. The
economic benefits of medical innovation
Andrew W. K. Farlow - The Department of Economics, Oriel College,
Oxford University. Costs of monopoly pricing under patent protection
Shubham Chaudhuri, Department of Economics, Columbia - Welfare
effects of TRIPS in India
2:30-3:30 R&D as a Global Good
James Orbinski, Centre for International Health, University of Toronto
(Moderator)
Robert Weissman - Co-Director, Essential Action. R&D in
international treaties
Nicoletta Dentico, M�decins Sans Fronti�res (MSF), Lessons from
the Tobacco Control and Landmine Conventions
Amy Kapczynski, Yale University - Best practices for management of
publicly funded R&D
Discussion
3:30-4:00 Coffee Break and showing of video clip from "Dying for
Drugs"
4:00 - 5:00 Open discussion: Priority-setting for analysis and
advocacy
Richard Nelson, Columbia University
James Love, Consumer Project on Technology
5:00-5:30 Wrap-Up: Where do we go from here?
Jeffrey Sachs, Columbia University
--
James Love, Director, Consumer Project on Technology
http://www.cptech.org, mailto:james.love@cptech.org
tel. +1.202.387.8030, mobile +1.202.361.3040
--
To send a message to E-Drug, write to: e-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug